PFO closure for prevention of recurrent stroke; Cost-effectiveness of triple therapy in RA

Published: Dec. 13, 2017, 2 p.m.

This episode of UpToDate Talk begins with Dr. Scott Kasner, who outlines three recent NEJM studies investigating the effects of PFO device closure on recurrent stroke risk. The second segment features Dr. James O’Dell, discussing the cost effectiveness of triple therapy in the treatment of rheumatoid arthritis. Dr. Helen Hollingsworth hosts.